Filing Details
- Accession Number:
- 0001127602-17-024126
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-25 18:53:21
- Reporting Period:
- 2017-07-21
- Filing Date:
- 2017-07-25
- Accepted Time:
- 2017-07-25 18:53:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334682 | H Gregg Alton | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp Comm&Acs Ala, Corp&Med Aff | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-07-21 | 34,500 | $26.99 | 137,488 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-07-21 | 34,500 | $74.00 | 102,988 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-07-21 | 5,500 | $74.00 | 97,488 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-07-21 | 34,500 | $0.00 | 34,500 | $26.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 29,626 | 2018-07-30 | No | 4 | M | Direct |
Footnotes
- The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Options vest over a five year period with 20% vesting July 30, 2009, the first anniversary of the grant. The options continue to vest in quarterly installments over the next four years, and will be fully vested on July 30, 2013.
Billionaire Hedge Funds
